Next Article in Journal
Alleviation of Lipid Disorder and Liver Damage in High-Fat Diet-Induced Obese Mice by Selenium-Enriched Cardamine violifolia with Cadmium Accumulation
Previous Article in Journal
Visceral Fat-Reducing Effect of Novel Dietary Intervention Program: A Randomized Controlled Trial in Japanese Males
Previous Article in Special Issue
Nutritional Status Indices and Monoclonal Gammopathy of Undetermined Significance Risk in the Elderly Population: Findings from the National Health and Nutrition Examination Survey
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Multifactorial Analysis of Influences on Quality of Life in Cancer Patients

1
Department of Food Market and Consumer Research, Institute of Human Nutrition Sciences, Warsaw University of Life Sciences (WULS-SGGW), 159C Nowoursynowska Street, 02-776 Warsaw, Poland
2
Cancer Epidemiology and Primary Prevention Department, Maria Sklodowska-Curie National Research Institute of Oncology, 15B Wawelska Street, 02-034 Warsaw, Poland
3
Department of Dietetics, Institute of Human Nutrition Sciences, Warsaw University of Life Sciences (WULS-SGGW), 159C Nowoursynowska Street, 02-776 Warsaw, Poland
4
Department of Human Nutrition, Faculty of Health Sciences, Medical University of Warsaw, 27 Erazma Ciolka Street, 01-445 Warsaw, Poland
5
Department of General Surgery and Clinical Nutrition, Centre of Postgraduate Medical Education in Warsaw, 231 Czerniakowska Street, 00-416 Warsaw, Poland
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Nutrients 2024, 16(18), 3207; https://doi.org/10.3390/nu16183207
Submission received: 26 August 2024 / Revised: 18 September 2024 / Accepted: 20 September 2024 / Published: 22 September 2024

Abstract

:
Background/Objectives: The diminished quality of life experienced by cancer patients impacts not only the individuals but also the broader healthcare system. Despite the effect that cancer has on quality of life both during and after treatment, quality of life assessments are not yet commonly implemented, and the specific factors influencing quality of life are not well understood. The aim of this study was to conduct comprehensive multifactorial analysis to identify the factors that influence the quality of life in cancer patients. Methods: This study comprised a cohort of 108 patients diagnosed with cancer. The EORTC QLQ C-30 and EORTC QLQ-INFO 25 questionnaires were used to interview participants, along with questions related to disease course and lifestyle factors. Results: Differences were found in various subdomains among male versus female, individuals who solicited nutritional information in cancer themselves versus those who did not, individuals who reported consulting a dietitian versus those who did not, individuals who reported a recent decrease in their food intake versus those who did not report it. The results of the stepwise multiple regression show the following factors as the most important factors affecting their quality of life: patients soliciting nutritional information, reduced food intake, types of nutrition support, age, gender, seeking consultation with a dietitian, place of residence, and education level. Conclusions: In addition to sociodemographic variables and those related to the location, course, and treatment of cancer, including type of cancer, the variable related to patients’ declared need for soliciting nutritional information and seeking consultation with a dietitian may also influence quality of life. Therefore, the above factors in determining the quality of life and well-being of patients should also be considered in a holistic approach to patient care.

1. Introduction

As the share of older people in Europe increases, approximately 21% (~95 billion) of Europeans are over the age of 65 in 2020. This demographic shift toward an older population is substantial. This demographic segment, which constitutes one-fifth of the European population, is expected to account for over 62% of newly diagnosed cancer cases (equating to 1.7 million cases) and approximately 76% (amounting to 0.98 million) of total cancer-related deaths [1]. In turn, age is a recognized factor contributing to cancer risk, hence the anticipation of not only a higher incidence of cancer cases but also an increase in the number of cancer survivors. Given that cancer is increasingly viewed as a chronic condition, it is emphasized to assess not only treatment effectiveness but also the broader aspects of quality of life, which can have lasting impacts on the patient’s life after treatment [2]. The monitoring and enhancement of the quality of life among cancer patients are integral components of Europe’s Cancer Beating Plan—an initiative that highlights the importance for clinicians and healthcare professionals to consider not only life expectancy but how patients will experience their lives after treatment [3].
The impaired quality of life in cancer patients affects individuals, families, and society as a whole. Cancer‘s total cost was around EUR 199 billion in 2018 in EU-27 plus Iceland, Norway, Switzerland, and the United Kingdom, and this health expenditure related to cancer has increased faster than the increase in cancer incidence. Although productivity losses from premature mortality decreased from EUR 77 to EUR 70 billion between 1995 and 2018, largely due to fewer cancer-related deaths in the working-age population, the impact of health-related quality of life on work performance requires further investigation [4].
The World Health Organization (WHO) defines quality of life as an individual‘s subjective evaluation of their life circumstances within the cultural and value frameworks of their society, relative to their goals, expectations, standards, and concerns [5]. Therefore, quality of life is influenced by numerous factors, making it a multidimensional concept. Among cancer patients, several key domains are commonly disrupted, including physical, mental, and social aspects. Patients undergoing treatment often experience symptoms such as fatigue, insomnia, pain, and loss of appetite. Additionally, anxiety, stress, and depression are frequently observed [6]. Conversely, long-term impacts on quality of life include disturbances in social, role, emotional, cognitive, and physical functioning. Patients may also experience persistent symptoms like dyspnea. Moreover, the aftermath of cancer may lead to future financial challenges [7]. Some studies have indicated that cancer survivorship can be linked with co-morbid depression, anxiety, and symptoms of post-traumatic stress disorder (PTSD) [8,9,10].
During the COVID pandemic, cancer patients were particularly affected, which may have influenced their perception of the disease. The literature widely documents the adverse effects of COVID-19 on cancer patients and survivors, including increased psychological distress, disruptions in treatment schedules, heightened infection risk due to compromised immune systems, and challenges in accessing healthcare services [11,12,13,14,15,16,17]. These factors could have significantly altered the experiences and perspectives of individuals dealing with cancer during this unprecedented time, highlighting the need for tailored support and comprehensive care strategies to address their unique needs.
To obtain a clear and reliable understanding of cancer patients’ quality of life, it is essential to use standardized tools dedicated to cancer patients. The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC QLQ-C30) is a widely recognized, standardized tool for assessing quality of life in cancer patients [18]. This questionnaire covers various domains such as the physical, role, emotional, cognitive, and social functioning, among others. Its comprehensive nature allows healthcare professionals to gain insights into the multifaceted impacts of cancer and its treatment on patients’ lives. Utilizing the EORTC QLQ-C30, healthcare providers can systematically evaluate patients’ quality of life, monitor changes over time, and customize interventions to address specific areas of concerns, thus facilitating patient-centered care and improving overall treatment outcomes [18].
To understand the influences on quality of life, it is important to consider specific clinical factors. Nutritional information and reduced food intake should be included in the assessment, as they may be related to treatment outcomes, as reduced food intake is linked to malnutrition. In particular, insight into cancer malnutrition can help in the design and implementation of oncology services to prevent poor patient outcomes [19]. Moreover, types of nutritional support and dietitian consultations reflect the proactive management of nutritional needs, which can improve patient well-being [20]. Additionally, sociodemographic factors such as age, gender, place of residence, and education level are often taken into consideration in clinical research because they have been identified as factors that influence the likelihood of malnutrition [19], and therefore, they can influence patient outcomes. Together, these factors could offer a comprehensive understanding of how various elements impact the quality of life in cancer patients, addressing key gaps in current research.
Despite growing awareness of cancer‘s impact on quality of life, current researches remain incomplete in key areas. It is crucial to thoroughly evaluate the factors influencing the severity and occurrence of factors affecting quality of life.. Identifying patient groups at higher risk of quality of life impairment and understanding avoidable factors that worsen quality of life appear to be crucial. Moreover, limited data exists on specific national contexts, such as Poland, where healthcare challenges may uniquely affect patient outcomes. This study addresses this gap with a multifactorial analysis of quality of life among Polish cancer patients, offering new insights in this area. Such research not only enhances understanding of the complexities surrounding cancer care but also enables the implementation of targeted support systems and interventions that can have a positive impact on the lives of those affected by cancer. These findings will contribute valuable data to better prepare for healthcare challenges and demographic shifts that are occurring. Therefore, the aim of this study was to conduct comprehensive multifactorial analysis to identify factors that influence quality of life in cancer patients. The findings aim to provide insights to guide targeted interventions and improve support systems to enhance the quality of life for cancer patients.

2. Materials and Methods

2.1. Ethical Statement

This study was conducted based on the guidelines of the Declaration of Helsinki. Each patient was informed of the purpose and nature of the research and provided their informed consent. The Bioethics Committee’s approval to conduct this study was obtained from the Bioethics Committee of the Medical Center for Postgraduate Education in Warsaw, Poland, on 14 July 2021, Order 116/2018.

2.2. Study Design and Setting

This cross-sectional study involved a cohort of patients diagnosed with cancer. Participants were recruited from two locations between January 2022 and September 2023: the Gastroenterology Unit at the Oncological Hospital in Warsaw, Poland, and the Polish Outpatient Clinic for Parenteral and Enteral Nutrition in Warsaw, Poland.

2.3. Study Population

The study sample included 108 patients diagnosed with cancer. Purposive sampling was used to select participants. Inclusion criteria were as follows: participants over 18 years of age, a confirmed cancer diagnosis, native Polish speakers, demonstrated linguistic and cognitive competence, and provided informed consent to participate. Exclusion criteria included participants who provided nonsensical or no information in the questionnaire.

2.4. Study Tools

Assessments were conducted weekly by a dietitian experienced in the field who consistently visited the hospital clinic. The measurement time points were set at weekly intervals throughout the study period. Each assessment was conducted at the same time each week to ensure consistency in data collection and include patient rotation in the ward. The overall duration of the data collection spanned from January 2022 to September 2023, during which the dietitian gathered data on quality of life and nutrition-related information from each eligible participant during every weekly visit. The EORTC QLQ-C30 questionnaire and EORTC QLQ-INFO 25 module were used to interview participants, along with questions related to disease course and lifestyle factors [21]. Information about the disease and its progression was verified in the patient‘s records.
The EORTC QLQ-C30 is a useful validated questionnaire [22], available in 122 official language versions [23]. The EORTC QLQ-INFO 25 questionnaire was administered with the EORTC QLQ-C30 and is a reliable and valid instrument [24], available in 33 official language versions [25].
Multi-item scales are used in the EORTC QLQ-C30 questionnaire, encompassing five functional scales (physical, role, cognitive, emotional, and social functioning), a global quality of life scale, and three symptom scales (fatigue, pain, and vomiting/nausea). Additionally, six individual symptom scales are included (dyspnoea, insomnia, loss of appetite, constipation, diarrhea, and financial difficulties). The standard version, Version 3.0, uses four-item scales for 28 questions and seven-item scales for assessing general health and quality of life over the past week. Responses range from 1 to 4 for the four-item scales and form 1 to 7 for the seven-item scales, which are then linearly transformed into a 0–100 scale. The EORTC QLQ-INFO 25 module specifically focuses on assessing the information needs of cancer patients, including satisfaction with information received, desire for more information, and perceived difficulty in understanding medical information. Using both the EORTC QLQ-C30 and EORTC QLQ-INFO 25 modules, this study aimed to provide a comprehensive understanding of not only the physical and psychological aspects of cancer patients’ quality of life but also their informational needs and experiences. This multifaceted approach allows for the exploration of the factors influencing patients’ overall well-being.
Moreover, an interview-based questionnaire, including both open-ended and closed-ended questions, was used to collect data on general sociodemographic characteristics. These included information on gender, age, educational level, place of residence, employment status, and economic situation (subjective assessment).
Weight loss was calculated based on current weight at clinic visits and self-reported weight six months before. Based on this, patients were categorized into those who had weight loss above and below 10%, as it has been indicated that weight loss of more than 10% in cancer patients is associated with deterioration in quality of life [26]. The Body Mass Index (BMI) was calculated based on weight (kg) divided by height (m) squared.
The nutritional status of each patient was evaluated by a qualified clinical dietitian using the Subjective Global Assessment (SGA) questionnaire results provided by a healthcare professional at the clinic. This evaluation also considered additional factors, including unintentional weight loss, reduced food intake, and disease progression, as documented in patient records and captured through questionnaire responses. The dietitian systematically reviewed these elements to form a comprehensive picture of the patient’s nutritional health. The process involved correlating data from the SGA with clinical observations and patient-reported information to ensure a thorough assessment.

2.5. Statistical Analysis

The Shapiro–Wilk test was applied to assess the normality of the distribution. Group comparisons were conducted using the chi-squared test, Student’s t-test for parametric distributions, and the Mann–Whitney U test for nonparametric distributions. The internal consistency of the EORTC QLQ-C30 scales was evaluated using Cronbach’s alpha coefficient, with a value of ≥0.70 considered as acceptable [27].
Stepwise multiple regression analysis was conducted, with the following variables: age, gender, education level, employment, place of residence, type of cancer, weight loss over 10%, BMI, economic situation, reduced food intake, patients soliciting nutritional information, types of nutrition support, and seeking consultation with a dietitian. The analysis reported both unstandardized and standardized β-coefficients accompanied by p-values. A significance level of p ≤ 0.05 was considered statistically significant. The statistical analysis was performed using Statistica 13.3 (StatSoft Inc., Tulsa, OK, USA).

3. Results

The sociodemographic characteristics of the patients are presented in Table 1. The median age of the study group was 60 years old, with BMI values interpreted as normal body mass in majority of the studied group, and approximately 10% weight loss observed recently. Over half of patients were women, with a predominant share of a higher education level, and nearly half of patients reported being retired. Around 30% of individuals lived in rural areas, as well as around 30% lived in large cities of over 500,000 inhabitants. Half of the patients reported reduced food consumption, and the majority of them solicited nutritional information related to their health status.
Cancer sites in the study group are presented in Table 2. More than half of the patients were diagnosed with head and neck cancer.
The results of the five functional scales, global quality of life scale, three symptom scales, and six individual symptom scales of EORTC QLQ-C30 are presented in Table 3. Cronbach’s alpha values for the individual scales ranged from fair (cognitive in functional scales) to very good (pain in symptom scales), indicating the reliability of this tool and the results obtained through it.
Table 4 presents the mean and median scores of the five functional scales, global quality of life scale, three symptom scales, and six individual symptom scales of the EORTC QLQ-C30, stratified by the gender of the analyzed group. Statistically significant differences were found in global health status and the cognitive, emotional, social subdomains (functional scale), as well as for the fatigue subdomain (symptom scale) between genders. Male patients scored higher than female patients in the following measures: the cognitive, emotional, and social subdomains and global health status. Female patients scored higher than male patients only in the fatigue subdomain. In the case of the physical subdomain (functional scale), a difference close to statistical significance was observed, and a tendency to higher scores in male patients may be indicated.
Table 5 presents the results of the five functional scales, global quality of life scale, three symptom scales, and six individual symptom scales of the EORTC QLQ-C30, stratified by the reported recent decrease in the food intake. Statistically significant differences were observed in global health status, the cognitive and emotional subdomains (functional scales), as well as for the pain (symptom scale), insomnia, and appetite loss subdomains (single-item measures) between individuals who reported a recent decrease in their food intake and those who did not report it. Individuals who did not report a recent decrease in their food intake scored higher than those who reported it in the cognitive and emotional subdomains, as well as in global health status. However, individuals who reported a recent decrease in their food intake scored higher in the pain (symptom scale), insomnia, and appetite loss subdomains (single-item measures) than those who did not report a reduced food intake.
Table 6 presents the results of the five functional scales, global quality of life scale, three symptom scales, and six individual symptom scales of the EORTC QLQ-C30, stratified by reporting to have consulted a dietitian. Statistically significant differences were found in the role and cognitive subdomains (functional scales), as well as for the fatigue (symptom scale) and appetite loss subdomain (single-item measure) between individuals who reported consulting a dietitian and those who did not. Individuals who did not report consulting a dietitian scored higher in the role and cognitive subdomains (functional scales), while individuals who reported consulting a dietitian scored higher in the fatigue (symptom scale) and appetite loss subdomains (single-item measure) than individuals who reported consulting a dietitian. In the case of the social subdomain (functional scale) and global health status, higher scores were observed for individuals who did not report consulting a dietitian than those who reported it, while for the pain subdomain (symptom scale), higher scores were observed for individuals who reported consulting a dietitian than those who did not. However, it should be noted that these latter relationships only indicate a trend (level close to the statistical significance).
In Table 7, the results of the five functional scales, global quality of life scale, three symptom scales, and six individual symptom scales of the EORTC QLQ-C30 are presented, stratified by having declared to have solicited nutritional information. Statistically significant differences were found in all functional scales (physical, role, cognitive, emotional, and social subdomains), in two out of three subdomains on the symptom scales (fatigue and pain subdomains), and in the insomnia subdomain (single-item measure), as well as in global health status between individuals who solicited nutritional information and those who did not. Individuals who did not solicit nutritional information scored higher in the physical, role, cognitive, emotional, and social subdomains (functional scales) than individuals who solicited nutritional information, whereas individuals who solicited nutritional information scored higher in the fatigue and pain subdomains (symptom scales), insomnia subdomain (single-item measure), and global health status than individuals who did not solicit nutritional information.
In Supplementary Table S1, the results of the five functional scales, global quality of life scale, three symptom scales, and six individual symptom scales of the EORTC QLQ-C30 are presented, stratified by patient education level. In Supplementary Table S2, the results of the five functional scales, global quality of life scale, three symptom scales, and six individual symptom scales of the EORTC QLQ-C30 are presented, stratified by place of residence. The analysis was conducted in larger subgroups due to their size.
Figure 1 presents a heatmap of the mean response score by age group. The heatmap visualizes the mean value across a spatial grid. Density scores were computed based on the number of data points assigned to each grid cell, with more intensive colors indicating higher densities, visualizing the number of points in each scale for each age group. Differences in the quality of life domains across various age groups can be observed.
Figure 2 shows a comparison of the main subscales’ measurements of the EORTC QLQ-C30 for orally and enterally fed patients in the study group. As seen on Figure 2, enterally fed patients achieved lower scores than orally fed patients for the role and social subdomains, as well as for general health status in the EORTC QLQ-C30. Simultaneously, enterally fed patients achieved higher scores than orally fed patients for the vomiting/nausea (p = 0.0308), dyspnea (p = 0.0306), and appetite loss subdomains (p = 0.0004) on the EORTC QLQ-C30 questionnaire.
Figure 3 shows a comparison of the main subscales’ measurements of the EORTC QLQ-C30 for different type of cancer groups. As shown in Figure 3, there is significant variation in the physical subdomain depending on different cancer location groups. Patients with reproductive system and lung cancers achieved lower scores than those with digestive system cancer, whereas digestive system cancer patients achieved similar scores in the physical subdomain as head and neck cancer patients in a post hoc analysis (p = 0.0347). This indicates the need for a specific approach to quality of life and its various domains depending on the type of cancer.
The results of the stepwise multiple regression analysis for the EORTC QLQ-C30 scale in a model that included age, gender, education level, employment status, place of residence, type of cancer, weight loss, over 10% weight loss, BMI, economic situation, reduced food intake, patients soliciting nutritional information, types of nutrition support, and reported to have consulted a dietitian as variables are presented in Supplementary Tables S1–S19, showing the results within each scale and measure. The analysis revealed that, depending on the scale of the EORTC QLQ-C30, various factors influenced the scores obtained. These factors included variables such as patients soliciting nutritional information, reduced food intake, types of nutrition support, age, gender, seeking consultation with a dietitian, place of residence, and education level.
An additional stepwise multiple regression analysis for the global health status (QoL) of the EORTC QLQ-C30 in a model with five functional scales (physical, role, cognitive, emotional, and social) and three symptom scales (fatigue, pain, and nausea/vomiting) is presented in Table 8. This analysis revealed that functional scales (physical and social subdomains) and appetite loss (single-items measures) had the greatest influence on the global health status (QoL).
In summary, the results of the stepwise multiple regression indicate that the following factors are the most important affecting the quality of life in a group of patients with various types of cancer: patients soliciting nutritional information, reduced food intake, types of nutrition support, age, gender, seeking consultation with a dietitian, place of residence, and education level.

4. Discussion

This study investigated various factors influencing quality of life among cancer patients, indicating the impact of patients soliciting nutritional information, reduced food intake, types of nutrition support, age, gender, seeking consultation with a dietitian, place of residence, and education level on quality of life aspects in cancer patients.
It is also important to understand the patient‘s attitude toward nutrition and their efforts to seek nutrition information, including their need for knowledge about the appropriate diet to follow during cancer treatment. Based on the multifactorial analysis, it was found that among the most important factors contributing to the varied outcomes in different domains of quality of life are soliciting nutritional information, reduced food intake, types of nutrition support, seeking consultation with a dietitian, and some sociodemographic variables (such as age, gender place of residence, and education level).

4.1. Quality of Life and Soliciting Nutritional Information

The presented study found that patients who did not actively seek information on nutrition tended to report higher scores across various functional domains, including physical, role, cognitive, emotional, and social functioning. This suggests that while seeking nutrition information may reflect underlying health challenges or higher anxiety levels, it could also indicate proactive patient engagement in managing their condition, as discussed in studies by Cook et al. [28] and Kenny et al. [29]. Despite the fact that nutritional information during cancer treatment may result in improved weight maintenance and energy intake, an overload of information received (or obtained from the internet) may lower the quality of life, especially for patients with low cognitive abilities. This excess information could be overwhelming or unclear, making it difficult for patients to remember and understand. In a study by Eraslan and Tufan [30], it was stated that patients’ searches for information about their treatments on the internet may cause cancer information overload (CIO), depression, and anxiety. The results of Posma et al.’s [31] study also indicate that patient education should be more tailored to specific needs of older cancer patients, given the decline in cognitive, vision, and hearing functions with age.

4.2. Quality of Life and Reduced Food Intake

Nutrition emerged as a critical determinant of QoL in this study. A significant number of patients experienced recent weight loss. This underscores the nutritional challenges and the need for intervention strategies to address this issue. Patients who had a recently reduced food intake exhibited poorer cognitive and emotional functioning and increased pain, insomnia, and appetite loss compared to those who did not experience such a reduction. This highlights the importance of proper food intake and interventions in enhancing patients’ overall well-being, consistent with findings from Keaver et al. [32] and Takata et al. [33].

4.3. Quality of Life and Types of Nutrition Support

While enteral nutrition is necessary for patients who cannot tolerate oral intake, the data from this study consistently suggest that oral nutrition is associated with better quality of life outcomes across multiple domains, including the role and social subdomains, as well as for general health status. This stays in line with results from Donohoe et al. [34] and Dashti et al. [35]. Especially notable is that Donohoe et al. [34] also indicated that in the majority of patients, despite supplemental nutrition, weight loss occurs, which may negatively impact the quality of life. Patients receiving enteral nutrition have more severe illnesses, including advanced cancer and higher rates of malnutrition, they more often have a more serious medical condition. They may also undergo more extensive medical treatments and procedures, which can contribute to poorer overall health and well-being outcomes compared to those who can maintain oral nutrition. However, patients relying on enteral feeding often encounter challenges that can negatively impact their quality of life. These challenges include physical discomfort from tube placement and maintenance, activity restrictions due to feeding schedules or mobility issues, and potential complications like infections or gastrointestinal discomfort. However, it should be notice that enteral nutrition has the best risk-benefit ratio for malnourished surgical cancer patients [36]. Considering this factors, lower scores of quality of life can be observed in patients receiving enteral nutrition due to additional factors.

4.4. Quality of Life and Age

Age was found to be a significant factor influencing quality of life outcomes in the study group. While the study did not show a significant impact of age on overall quality of life or functional scales, older patients consistently reported higher scores in specific symptom-related areas such as insomnia and diarrhea. This indicates that age may play a role in certain symptoms experienced by cancer patients, although the effect sizes were modest. This finding aligns with previous research by Shrestha et al. [37], which emphasizes that advancing age correlates with diminished QoL parameters in cancer patients. In Ligt et al. study [38], it was found that older age significantly influences deterioration in the physical functioning scores but improves emotional functioning scores. In this study, it was observed that higher cognitive functioning scores were found in younger patients. However, it should be noted that the study group was generally older (median age was 60.0 years) than in Ligt et al. [38] study (mean age was 54.0 years). The implications suggest that interventions tailored to address age-related challenges could potentially enhance overall QoL among older cancer patients. Effective care for elderly cancer patients should prioritize these domains that are most influenced.

4.5. Quality of Life and Gender

Across various domains of quality of life assessed by the EORTC QLQ-C30 scale, being male generally was associated with better functional scales scores (cognitive, emotional, and social subdomains) and global health status as quality of life outcomes. These findings suggest that gender differences may influence how cancer patients perceive and experience their quality of life, with males potentially experiencing better cognitive, emotional, social functioning, lower fatigue levels, and better overall quality of life compared to females scoring higher in fatigue related scale in this study population. Similar gender differences have been documented in studies by Tarar et al. [39] and Jehn et al. [40], highlighting those tailored approaches in cancer care, sensitive to gender-specific needs and challenges, are essential for optimizing QoL outcomes. Nevertheless, it should be noted that while the impact of gender varies across the EORTC QLQ-C30 scales as reported in the conducted study, the influence of health conditions remains highly significant. These studies collectively emphasize the importance of a gender-sensitive approach in cancer care, recognizing the distinct needs and challenges faced by men and women. Addressing these differences can improve quality of life outcomes and provide more effective support for cancer patients.

4.6. Quality of Life and Seeking Consultation with a Dietitian

This study highlights a significant association between consulting a dietitian and better scores in several domains related to quality of life (QoL). Specifically, patients who sought dietary consultation experienced more fatigue, pain, and insomnia, but reported a better overall health perception. Simultaneously, individuals who did not seek nutritional information had higher scores on the functional scales, which assess physical, role, cognitive, emotional, and social functioning. This observation aligns with the broader literature, which suggests that nutritional counseling can play a significant role in managing both physical and psychological aspects of health in cancer patients [32,33,34,35,36,37,38,39,40,41,42,43]. Despite their awareness of the need for dietary consultations, cancer patients may still face increased stress and information overload [44]. Especially considering the fact that cancer patients experience some impact of the disease on their food intake, which likely includes the dietary recommendations provided by a dietitian. These psychological aspects affecting food consumption may be linked with behavioral responses such as learned food aversions, changes in food preferences, and anticipatory nausea and vomiting [45]. This may contribute to a deeper sense of being overwhelmed by conflicting messages. Consequently, this could result in lower scores in the cognitive scale (especially concerning questions like: ‘Did you have difficulties remembering?’). It should be noted that feeling overwhelmed by conflicting information may not stem from a single source [44]. However, the availability of nutritional counseling remains a critical issue. In Poland, despite the recognized benefits, nutritional counseling services are not sufficiently widespread to meet the needs of all cancer patients. Hospitals employ a relatively small number of dietitians, and the estimated duration of a dietetic consultation, including the measurement of lean body mass and a nutritional interview, is just 30 min [46]. This limitation raises concerns about the accessibility and equity of nutritional care within the healthcare system. It appears that patients who seek out nutritional counseling independently may be those who are either particularly motivated or facing more severe health challenges. This situation reflect a disparity where only a subset of patients benefits from nutritional guidance, which is reflected in a studied group within association between seeking consulting a dietitian and reduced cognitive function, as it may be supposed, that patients with reduced cognitive function may need additional support [47].
Taking into account the need for deepen dietary counseling, the problem is associated with inadequate support in this area. Sullivan et al. [48] reported that only a small fraction of cancer survivors had access to a registered dietitian. Many survivors, faced conflicting nutrition information from various sources, turned to alternative dietary strategies or engaged in high levels of food avoidance. This confusion highlights the critical need for reliable and consistent nutritional guidance, which is currently lacking in many cancer care settings. Similar observations are made by Trujillo et al. [49], who states that lack of access to nutrition care in outpatient cancer centers is a critical issue in the U.S. healthcare system. Furthermore, van Dongen et al. [50] highlighted the increasing expectation, both from formal and informal caregivers, as well as from cancer patients themselves, to self-manage their diets. Their findings also indicated that a significant proportion of patients—70–82%—adopted balanced diets, which were linked to improvements in QoL, increased strength, and better symptom management [50]. This study supports the benefits of consulting a dietitian, but also highlights systemic challenges. The disparity in access to nutritional counseling services indicates that broader implementation and integration of these services within healthcare systems are essential. Future research should explore strategies to increase the availability and accessibility of nutritional counseling to ensure that all cancer patients can benefit from these critical support services.

4.7. Quality of Life and Place of Residence

The findings of the presented study suggest that the place of residence may influence declared symptoms related to quality of life, such as insomnia. However, in this study, this variable had a significant impact only when combined with other variables in a multivariate analysis characterizing the group. Nevertheless, it should be noted that the primary impact of residence is likely on access to medical care and support services. A systematic review by Afshar et al. [51] indicates that, in most studies, rural cancer patients often experience worse survival outcomes compared to their urban counterparts, potentially due to urban-rural disparities in healthcare access. These disparities may also affect the severity of symptoms in cancer patients. Additionally, the location of residence can impact the availability of support services, such as nutritional counseling and psychological support. Payne et al. [52] highlight that patients residing far from hospitals may experience increased emotional and psychological distress during hospital stays, which can exacerbate symptoms. Furthermore, the strength of social networks and community support can vary by location as stated by Carnahan at al. [53]. Patients in close-knit communities may receive greater emotional support and practical assistance, which can positively influence their quality of life [51]. However the relationship between place of residence and quality of life requires further research.

4.8. Quality of Life and Education Level

The presented research suggests that the educational level of cancer patients may significantly impact their QoL, particularly in domains such as physical and cognitive functioning as well as in the fatigue domain. Higher educational levels are correlated with better scores in the fatigue subdomain, but not on the physical and cognitive functioning scales. Konieczny et al. [54] found that higher QoL—measured by functional scales and symptom intensity—was, among other factors, linked to higher education level, and a favorable financial situation. Higher education might be associated with higher income, contributing to better well-being and a greater sense of security. Better-educated patients may also have a better understanding of their medical situation and procedures, which could influence QoL. Moreover, Fiscella et al. [55] found that patients with lower levels of education received slightly less time for answering their questions, exercise counseling, assessing their health knowledge, and negotiating. In terms of fatigue, it is worth noting that Avancini et al. [56] reported that cancer patients with a higher education level showed a greater willingness to engage in physical exercise. This increased motivation for exercise may contribute to be more physically fit and become tired less easily. This finding is consistent with the hypothesis that higher education is associated with improved health literacy and greater adherence to medical and nutritional advice, as evidenced by Nilsen et al. [57] in their study on cancer survivors. In conclusion, the level of education appears to have a meaningful impact on various dimensions of QoL in cancer patients, potentially through its influence on physical health, symptom management, and the adherence to health recommendations.

4.9. Study Limitations

This study has several limitations, including a small sample size, its focus on a single geographic region and clinic selection, a cross-sectional design preventing causal conclusions, and potential reporting bias. Future research should aim to address these limitations to more comprehensively understand the factors influencing the quality of life of cancer patients.

5. Conclusions

This study identifies differences in quality of life and symptom management across different patient sociodemographic and health behaviors, highlighting the importance of personalized nutritional and psychological support in improving patient outcomes. Univariate and multivariate analysis indicated that, in addition to sociodemographic variables and those related to the location, course, and treatment of cancer, including types of cancer, variables related to patients’ declared need for soliciting nutritional information and seeking consultation with a dietitian may also influence quality of life. While seeking nutrition information may reflect underlying health challenges, an excess of information could be overwhelming, making it difficult for patients to remember and understand. Therefore, these factors influencing the quality of life and well-being of patients should be integrated into a holistic approach to patient care. Healthcare providers should incorporate nutritional counseling tailored to cognitive abilities as part of patient care to enhance both quality of life and patient outcomes. The findings of this study could further enhance our understanding of the quality of life in cancer patients.

Supplementary Materials

The following supporting information can be downloaded at https://www.mdpi.com/article/10.3390/nu16183207/s1, Table S1: Results of the five functional scales, global quality of life scale, three symptom scales, and six individual symptom scales of the EORTC QLQ-C30, stratified by level of education; Table S2: Results of the five functional scales, global quality of life scale, three symptom scales, and six individual symptom scales of the EORTC QLQ-C30, stratified by place of residence; Table S3: Results of stepwise multiple regression analysis for sum on scale of EORTC QLQ-C30 (n = 108); Table S4: Results of stepwise multiple regression analysis for role domain on scale of EORTC QLQ-C30 (n = 108); Table S5: Results of stepwise multiple regression analysis for physical domain on the scale of EORTC QLQ-C30 (n = 108); Table S6: Results of stepwise multiple regression analysis for cognitive domain of scale of EORTC QLQ-C30 (n = 108); Table S7: Results of stepwise multiple regression analysis for emotional domain of scale of EORTC QLQ-C30 (n = 108); Table S8: Results of stepwise multiple regression analysis for emotional domain of scale of EORTC QLQ-C30 (n = 108); Table S9: Results of stepwise multiple regression analysis for social domain of scale of EORTC QLQ-C30 (n = 108); Table S10: Results of stepwise multiple regression analysis for fatigue domain of scale of EORTC QLQ-C30 (n = 108); Table S11: Results of stepwise multiple regression analysis for pain domain of scale of EORTC QLQ-C30 (n = 108); Table S12: Results of stepwise multiple regression analysis for vomiting/nausea domain of scale of EORTC QLQ-C30 (n = 108); Table S13: Results of stepwise multiple regression analysis for dyspnea domain of scale of EORTC QLQ-C30 (n = 108); Table S14: Results of stepwise multiple regression analysis for insomnia domain of scale of EORTC QLQ-C30 (n = 108); Table S15: Results of stepwise multiple regression analysis for appetite loss domain of scale of EORTC QLQ-C30 (n = 108); Table S16: Results of stepwise multiple regression analysis for constipation domain of scale of EORTC QLQ-C30 (n = 108); Table S17: Results of stepwise multiple regression analysis for diarrhea domain of scale of EORTC QLQ-C30 (n = 108); Table S18: Results of stepwise multiple regression analysis for financial difficulties domain of scale of EORTC QLQ-C30 (n = 108); Table S19: Results of stepwise multiple regression analysis for global health status (QoL) of EORTC QLQ-C30 (n = 108).

Author Contributions

E.G.—conceptualization; data curation; formal analysis; investigation; methodology; project administration; resources; visualization; writing—original draft; and writing—review and editing; D.G. (Dominika Głąbska)—data curation; formal analysis; investigation; methodology; resources; visualization; writing—original draft; and writing—review and editing; Z.Z.—data curation; formal analysis; investigation; methodology; resources; visualization; and writing—review and editing; J.S.—data curation; formal analysis; investigation; methodology; project administration; resources; and writing—review and editing; D.G. (Dominika Guzek)—conceptualization; data curation; formal analysis; investigation; methodology; project administration; resources; supervision; writing—original draft; and writing—review and editing. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the Polish Ministry of Education Science with funds from the Warsaw University of Life Sciences in Warsaw (WULS), for scientific research.

Institutional Review Board Statement

This study was conducted based on the guidelines of the Declaration of Helsinki. Each patient was informed of the purpose and nature of the research and gave informed consent. The Bioethics Committee’s approval to conduct the study was obtained from the Bioethics Committee of the Medical Centre for Postgraduate Education in Warsaw, Poland, on 14 July 2021, Order 116/2018.

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

The data presented in this study are available on request from the corresponding author. The data are not publicly available due to ethical restrictions.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Munoz-Pineiro, M.A.; Stepien, M.; Randi, G.; Louro, C.S. Cancer in 2040: Estimates for an Ageing Europe. JRC Publications Repository. Available online: https://publications.jrc.ec.europa.eu/repository/handle/JRC133792 (accessed on 6 April 2024).
  2. Dyba, T.; Randi, G.; Bray, F.; Martos, C.; Giusti, F.; Nicholson, N.; Gavin, A.; Flego, M.; Neamtiu, L.; Dimitrova, N.; et al. The European Cancer Burden in 2020: Incidence and Mortality Estimates for 40 Countries and 25 Major Cancers. Eur. J. Cancer 2021, 157, 308–347. [Google Scholar] [CrossRef] [PubMed]
  3. Europe’s Beating Cancer Plan Communication from the Commission to the European Parliament and the Council. Available online: https://health.ec.europa.eu/system/files/2022-02/eu_cancer-plan_en_0.pdf (accessed on 15 June 2024).
  4. Hofmarcher, T.; Lindgren, P.; Wilking, N.; Jönsson, B. The Cost of Cancer in Europe 2018. Eur. J. Cancer 2020, 129, 41–49. [Google Scholar] [CrossRef] [PubMed]
  5. World Health Organization. WHOQOL—Measuring Quality of Life | The World Health Organization. Available online: https://www.who.int/toolkits/whoqol (accessed on 17 September 2024).
  6. Salvetti, M.d.G.; Machado, C.S.P.; Donato, S.C.T.; da Silva, A.M. Prevalence of Symptoms and Quality of Life of Cancer Patients. Rev. Bras. De Enferm. 2020, 73, e20180287. [Google Scholar] [CrossRef] [PubMed]
  7. Arndt, V.; Koch-Gallenkamp, L.; Jansen, L.; Bertram, H.; Eberle, A.; Holleczek, B.; Schmid-Höpfner, S.; Waldmann, A.; Zeissig, S.R.; Brenner, H. Quality of Life in Long-Term and Very Long-Term Cancer Survivors versus Population Controls in Germany. Acta Oncol. 2017, 56, 190–197. [Google Scholar] [CrossRef] [PubMed]
  8. Gurevich, M.; Devins, G.M.; Rodin, G.M. Stress Response Syndromes and Cancer: Conceptual and Assessment Issues. Psychosomatics 2002, 43, 259–281. [Google Scholar] [CrossRef]
  9. Koutrouli, N.; Anagnostopoulos, F.; Potamianos, G. Posttraumatic Stress Disorder and Posttraumatic Growth in Breast Cancer Patients: A Systematic Review. Women Health 2012, 52, 503–516. [Google Scholar] [CrossRef]
  10. Kangas, M.; Henry, J.L.; Bryant, R.A. Posttraumatic Stress Disorder Following Cancer. Clin. Psychol. Rev. 2002, 22, 499–524. [Google Scholar] [CrossRef]
  11. Ciążyńska, M.; Pabianek, M.; Szczepaniak, K.; Ułańska, M.; Skibińska, M.; Owczarek, W.; Narbutt, J.; Lesiak, A. Quality of Life of Cancer Patients during Coronavirus Disease (COVID-19) Pandemic. Psycho Oncol. 2020, 29, 1377–1379. [Google Scholar] [CrossRef]
  12. Jeppesen, S.S.; Bentsen, K.K.; Jørgensen, T.L.; Holm, H.S.; Holst-Christensen, L.; Tarpgaard, L.S.; Dahlrot, R.H.; Eckhoff, L. Quality of Life in Patients with Cancer during the COVID-19 Pandemic—A Danish Cross-Sectional Study (COPICADS). Acta Oncol. 2021, 60, 4–12. [Google Scholar] [CrossRef]
  13. Baffert, K.-A.; Darbas, T.; Lebrun-LY, V.; Pestre-Munier, J.; Peyramaure, C.; Descours, C.; Mondoly, M.; Latrouite, S.; Bignon, E.; Nicouleau, S.; et al. Quality of Life of Patients with Cancer during the COVID-19 Pandemic. In Vivo 2021, 35, 663–670. [Google Scholar] [CrossRef]
  14. Bargon, C.; Batenburg, M.; Van Stam, L.; van der Molen, D.M.; Van Dam, I.; van der Leij, F.; Baas, I.; Ernst, M.; Maarse, W.; Vermulst, N.; et al. The Impact of the COVID-19 Pandemic on Quality of Life, Physical and Psychosocial Wellbeing in Breast Cancer Patients—A Prospective, Multicenter Cohort Study. Eur. J. Cancer 2020, 138, S17. [Google Scholar] [CrossRef]
  15. Tabaczynski, A.; Bastas, D.; Whitehorn, A.; Trinh, L. Changes in Physical Activity and Associations with Quality of Life among a Global Sample of Cancer Survivors during the COVID-19 Pandemic. J. Cancer Surviv. 2022, 17, 1191–1201. [Google Scholar] [CrossRef] [PubMed]
  16. Gallo, O.; Bruno, C.; Locatello, L.G.; Martelli, F.; Cilona, M.; Orlando, P.; Fancello, G.; Maggiore, G.; Viberti, F.; Ciabatti, P.; et al. The Impact of the COVID-19 Pandemic on the Quality of Life of Head and Neck Cancer Survivors. Support. Care Cancer 2021, 29, 6297–6304. [Google Scholar] [CrossRef] [PubMed]
  17. Helm, E.E.; Kempski, K.A.; Galantino, M.L.A. Effect of Disrupted Rehabilitation Services on Distress and Quality of Life in Breast Cancer Survivors during the COVID-19 Pandemic. Rehabil. Oncol. 2020, 38, 153–158. [Google Scholar] [CrossRef]
  18. Wintner, L.M.; Sztankay, M.; Aaronson, N.; Bottomley, A.; Giesinger, J.M.; Groenvold, M.; Petersen, M.A.; van de Poll-Franse, L.; Velikova, G.; Leeuw, I.V.-D.; et al. The use of EORTC measures in daily clinical practice—A synopsis of a newly developed manual. Eur. J. Cancer 2016, 68, 73–81. [Google Scholar] [CrossRef]
  19. Marshall, K.M.; Loeliger, J.; Nolte, L.; Kelaart, A.; Kiss, N.K. Prevalence of malnutrition and impact on clinical outcomes in cancer services: A comparison of two time points. Clin. Nutr. 2019, 38, 644–651. [Google Scholar] [CrossRef]
  20. Gomes, F.; Baumgartner, A.; Bounoure, L.; Bally, M.; Deutz, N.E.; Greenwald, J.L.; Stanga, Z.; Mueller, B.; Schuetz, P. Association of nutritional support with clinical outcomes among medical inpatients who are malnourished or at nutritional risk: An updated systematic review and meta-analysis. JAMA Netw. Open 2019, 2, e1915138. [Google Scholar] [CrossRef]
  21. Groenvold, M.; Klee, M.C.; Sprangers, M.A.; Aaronson, N.K. Validation of the EORTC QLQ-C30 quality of life questionnaire through combined qualitative and quantitative assessment of patient-observer agreement. J. Clin. Epidemiol. 1997, 50, 441–450. [Google Scholar] [CrossRef]
  22. Scott, N.; Fayers, P.; Aaronson, N.; Bottomley, A.; de Graeff, A.; Groenvold, M.; Gundy, C.; Koller, M.; Petersen, M.A.; Sprangers, M.A.G. EORTC QLQ-C30. Reference Values. Brussels: EORTC. 2008. Available online: https://www.eortc.org/app/uploads/sites/2/2018/02/reference_values_manual2008.pdf (accessed on 15 June 2024).
  23. EORTC QLQ-C30. Quality of Life of Cancer Patients. Translations. Available online: https://qol.eortc.org/questionnaire/eortc-qlq-c30/ (accessed on 19 July 2024).
  24. Arraras, J.I.; Greimel, E.; Sezer, O.; Chie, W.C.; Bergenmar, M.; Costantini, A.; Young, T.; Vlasic, K.K.; Velikova, G. An international validation study of the EORTC QLQ-INFO25 questionnaire: An instrument to assess the information given to cancer patients. Eur. J. Cancer 2010, 46, 2726–2738. [Google Scholar] [CrossRef]
  25. EORTC QLQ–INFO25—Quality of Life of Cancer Patients Translations. Available online: https://qol.eortc.org/questionnaire/qlq-info25/ (accessed on 19 July 2024).
  26. Langius, J.A.E.; van Dijk, A.M.; Doornaert, P.; Kruizenga, H.M.; Langendijk, J.A.; Leemans, C.R.; Weijs, P.J.M.; Leeuw, I.M.V.-D. More than 10% weight loss in head and neck cancer patients during radiotherapy is independently associated with deterioration in quality of life. Nutr. Cancer 2013, 65, 76–83. [Google Scholar] [CrossRef]
  27. Nunnally, J.C.; Bernstein, I.H. Psychometric Theory; McGraw-Hill: New York, NY, USA, 1994. [Google Scholar]
  28. Cook, F.; Rodriguez, J.M.; McCaul, L.K. Malnutrition, nutrition support and dietary intervention: The role of the dietitian supporting patients with head and neck cancer. Br. Dent. J. 2022, 233, 757–764. [Google Scholar] [CrossRef] [PubMed]
  29. Kenny, E.; Touger-Decker, R.; August, D.A. Structured review of the value added by the registered dietitian to the care of gastrointestinal cancer patients. Nutr. Clin. Pract. 2021, 36, 606–628. [Google Scholar] [CrossRef] [PubMed]
  30. Eraslan, P.; Tufan, G. Cancer information overload may be a crucial determinant of adjuvant aromatase inhibitor adherence. Eur. Rev. Med. Pharmacol. Sci. 2022, 26, 7053–7062. [Google Scholar] [CrossRef] [PubMed]
  31. Posma, E.R.; van Weert, J.C.; Jansen, J.; Bensing, J.M. Older cancer patients’ information and support needs surrounding treatment: An evaluation through the eyes of patients, relatives and professionals. BMC Nurs. 2009, 8, 1. [Google Scholar] [CrossRef] [PubMed]
  32. Keaver, L.; O’Callaghan, N.; Douglas, P. Nutrition support and intervention preferences of cancer survivors. J. Hum. Nutr. Diet. 2023, 36, 526–539. [Google Scholar] [CrossRef]
  33. Takata, N.; Kikuchi, S.; Kuroda, S.; Tanabe, S.; Maeda, N.; Noma, K.; Takahashi, A.; Umeda, Y.; Shikata, K.; Ozaki, K.; et al. Effect of patient-participation continuous nutritional counseling in gastric cancer patients who underwent gastrectomy. Ann. Sur. Oncol. 2023, 30, 1110–1118. [Google Scholar] [CrossRef]
  34. Donohoe, C.L.; Healy, L.A.; Fanning, M.; Doyle, S.L.; Hugh, A.M.; Moore, J.; Reynolds, J.V. Impact of supplemental home enteral feeding postesophagectomy on nutrition, body composition, quality of life, and patient satisfaction. Dis. Esophagus 2017, 30, 1–9. [Google Scholar] [CrossRef]
  35. Dashti, H.S.; Godbole, M.; Chen, A.; Mogensen, K.M.; Leong, A.; Burns, D.L.; Winkler, M.F.; Saxena, R.; Compher, C. Sleep patterns of patients receiving home parenteral nutrition: A home-based observational study. J. Parenter. Enter. Nutr. 2022, 46, 1699–1708. [Google Scholar] [CrossRef]
  36. Sandrucci, S.; Cotogni, P.; De Zolt Ponte, B. Impact of Artificial Nutrition on Postoperative Complications. Healthcare 2020, 8, 559. [Google Scholar] [CrossRef]
  37. Shrestha, A.; Martin, C.; Burton, M.; Walters, S.; Collins, K.; Wyld, L. Quality of life versus length of life considerations in cancer patients: A systematic literature review. Psycho Oncol. 2019, 28, 1367–1380. [Google Scholar] [CrossRef]
  38. de Ligt, K.M.; Aaronson, N.K.; Liegl, G.; Nolte, S.; EORTC Quality of Life Group. Updated normative data for the EORTC QLQ-C30 in the general Dutch population by age and sex: A cross-sectional panel research study. Qual Life Res. 2023, 32, 2477–2487. [Google Scholar] [CrossRef] [PubMed]
  39. Tarar, A.H.; Shaloom, A. Cancer and Quality of Life: Importance of Gender and Marital Adjustment in Psycho-Social Oncology. Pak. Armed Forces Med. J. 2020, 70, 734–739. [Google Scholar]
  40. Jehn, P.; Spalthoff, S.; Lentge, F.; Zeller, A.N.; Tavassol, F.; Neuhaus, M.T.; Korn, P. Postoperative quality of life and therapy-related impairments of oral cancer in relation to time–distance since treatment. J. Cancer Surviv. 2022, 16, 1366–1378. [Google Scholar] [CrossRef] [PubMed]
  41. Orell, H.; Schwab, U.; Saarilahti, K.; Österlund, P.; Ravasco, P.; Mäkitie, A. Nutritional counseling for head and neck cancer patients undergoing (chemo) radiotherapy—A prospective randomized trial. Front. Nutr. 2019, 6, 22. [Google Scholar] [CrossRef]
  42. Van der Werf, A.; Langius, J.A.E.; Beeker, A.; Ten Tije, A.J.; Vulink, A.J.; Haringhuizen, A.; Berkhof, J.; van der Vliet, H.J.; Verheul, H.M.W.; de van der Schueren, M.A.E. The effect of nutritional counseling on muscle mass and treatment outcome in patients with metastatic colorectal cancer undergoing chemotherapy: A randomized controlled trial. Clin. Nutr. 2020, 39, 3005–3013. [Google Scholar] [CrossRef]
  43. Ho, Y.W.; Yeh, K.Y.; Hsueh, S.W.; Hung, C.Y.; Lu, C.H.; Tsang, N.M.; Wang, H.M.; Hung, Y.S.; Chou, W.C. Impact of early nutrition counseling in head and neck cancer patients with normal nutritional status. Support. Care Cancer 2021, 29, 2777–2785. [Google Scholar] [CrossRef]
  44. Ramondt, S.; Ramírez, A.S. Assessing the impact of the public nutrition information environment: Adapting the cancer information overload scale to measure diet information overload. Patient Educ. Couns. 2019, 102, 37–42. [Google Scholar] [CrossRef]
  45. Padilla, G.V. Psychological Aspects of Nutrition and Cancer. Surg. Oncol. Clin. N. 1986, 66, 1121–1135. [Google Scholar] [CrossRef] [PubMed]
  46. Jankowski, M.; Qelaj, A.; Klek, S.; Murawa, D.; Nartowicz, M.; Patela, Z.; Mańkowska-Wierzbicka, D.; Kapała, A.; Kuczyńska, B.; Zegarski, W. The role of comprehensive nutritional care in cancer patients. Nowotw. J. Oncol. 2021, 71, 158–161. [Google Scholar] [CrossRef]
  47. Collins, R.; Hunt, A.; Quinn, C.; Martyr, A.; Pentecost, C.; Clare, L. Methods and approaches for enhancing communication with people with moderate-to-severe dementia that can facilitate their inclusion in research and service evaluation: Findings from the IDEAL programme. Dementia 2022, 21, 1135–1153. [Google Scholar] [CrossRef]
  48. Sullivan, E.S.; Rice, N.; Kingston, E.; Kelly, A.; Reynolds, J.V.; Feighan, J.; Power, D.G.; Ryan, A.M. A national survey of oncology survivors examining nutrition attitudes, problems and behaviours, and access to dietetic care throughout the cancer journey. Clin. Nutr. ESPEN 2021, 41, 331–339. [Google Scholar] [CrossRef] [PubMed]
  49. Trujillo, E.B.; Dixon, S.W.; Claghorn, K.; Levin, R.M.; Mills, J.B.; Spees, C.K. Closing the Gap in Nutrition Care at Outpatient Cancer Centers: Ongoing Initiatives of the Oncology Nutrition Dietetic Practice Group. J. Acad. Nutr. Diet. 2018, 118, 749–760. [Google Scholar] [CrossRef] [PubMed]
  50. van Dongen, S.I.; de Nooijer, K.; Cramm, J.M.; Francke, A.L.; Oldenmenger, W.H.; Korfage, I.J.; E Witkamp, F.; Stoevelaar, R.; van der Heide, A.; Rietjens, J.A. Self-management of patients with advanced cancer: A systematic review of experiences and attitudes. Palliat. Med. 2020, 34, 160–178. [Google Scholar] [CrossRef]
  51. Afshar, N.; English, D.R.; Milne, R.L. Rural–urban residence and cancer survival in high-income countries: A systematic review. Cancer 2019, 125, 2172–2184. [Google Scholar] [CrossRef] [PubMed]
  52. Payne, S.; Jarrett, N.; Jeffs, D.; Brown, L. Implications of social isolation during cancer treatment.: The implications of residence away from home during cancer treatment on patients’ experiences: A comparative study. Health Place 2021, 7, 273–282. [Google Scholar] [CrossRef]
  53. Carnahan, L.R.; Rauscher, G.H.; Watson, K.S.; Altfeld, S.; Zimmermann, K.; Ferrans, C.E.; Molina, Y. Comparing the roles of social context, networks, and perceived social functioning with health-related quality of life among self-reported rural female cancer survivors. Support. Care Cancer 2021, 29, 331–340. [Google Scholar] [CrossRef]
  54. Konieczny, M.; Cipora, E.; Sygit, K.; Fal, A. Quality of Life of Women with Breast Cancer and Socio-Demographic Factors. Asian Pac. J. Cancer Prev. 2020, 21, 185–193. [Google Scholar] [CrossRef]
  55. Fiscella, K.; Goodwin, M.A.; Stange, K.C. Does patient educational level affect office visits to family physicians? J. Natl. Med. Assoc. 2002, 94, 157–165. [Google Scholar]
  56. Avancini, A.; Pala, V.; Trestini, I.; Tregnago, D.; Mariani, L.; Sieri, S.; Krogh, V.; Boresta, M.; Milella, M.; Pilotto, S.; et al. Exercise levels and preferences in cancer patients: A cross-sectional study. Int. J. Environ. Res. Public Health 2020, 17, 5351. [Google Scholar] [CrossRef]
  57. Nilsen, M.L.; Moskovitz, J.; Lyu, L.; Harrison, C.; Randazza, E.; Peddada, S.D.; Johnson, J.T. Health literacy: Impact on quality of life in head and neck cancer survivors. Laryngoscope 2020, 130, 2354–2359. [Google Scholar] [CrossRef]
Figure 1. Heatmap of mean response score by age group.
Figure 1. Heatmap of mean response score by age group.
Nutrients 16 03207 g001
Figure 2. The comparison of the main subscales’ measurements of the EORTC QLQ-C30 for orally and enterally fed patients in the study group. The solid line represents the results obtained in points for individual subscales within the enteral nutrition group, while the dashed line corresponds to the results obtained in points for individual subscales within the oral nutrition group. The shaded areas indicate the confidence intervals (CIs). An asterisk indicates statistical significance at the level of p ≤ 0.05.
Figure 2. The comparison of the main subscales’ measurements of the EORTC QLQ-C30 for orally and enterally fed patients in the study group. The solid line represents the results obtained in points for individual subscales within the enteral nutrition group, while the dashed line corresponds to the results obtained in points for individual subscales within the oral nutrition group. The shaded areas indicate the confidence intervals (CIs). An asterisk indicates statistical significance at the level of p ≤ 0.05.
Nutrients 16 03207 g002
Figure 3. The comparison of the main subscales’ measurements of the EORTC QLQ-C30 for different type of cancer groups. The solid blue line represents the results obtained in points for individual subscales within digestive system cancer patients, the solid red line represents the results obtained in points for individual subscales within reproductive system cancer patients, and the dashed line corresponds to the results obtained in points for individual subscales within the head and neck cancer patient group. The shaded areas indicate the confidence intervals (CIs). An asterisk indicates statistical significance at the level of p ≤ 0.05.
Figure 3. The comparison of the main subscales’ measurements of the EORTC QLQ-C30 for different type of cancer groups. The solid blue line represents the results obtained in points for individual subscales within digestive system cancer patients, the solid red line represents the results obtained in points for individual subscales within reproductive system cancer patients, and the dashed line corresponds to the results obtained in points for individual subscales within the head and neck cancer patient group. The shaded areas indicate the confidence intervals (CIs). An asterisk indicates statistical significance at the level of p ≤ 0.05.
Nutrients 16 03207 g003
Table 1. Sociodemographic characteristics of patients.
Table 1. Sociodemographic characteristics of patients.
CharacteristicsNumber (%)
GenderWoman58 (53.7%)
Man50 (46.29%)
Education levelHigher49 (45.37%)
General secondary36 (33.33%)
Vocational secondary22 (20.37%)
Primary1 (0.93%)
EmploymentFull-time permanent28 (25.93%)
Part-time permanent4 (3.70%)
Full- or parti-time temporary5 (4.63%)
Pension7 (6.48%)
Retirement50 (46.30%)
Not employed14 (12.96%)
Place of residenceRural area36 (33.33%)
Town, up to 20,000 inhabitants14 (12.96%)
City, 20,000 to 100,000 inhabitants21 (19.44%)
City, 100,000 to 500,000 inhabitants5 (4.63%)
City, over 500,000 inhabitants32 (29.63%)
>10% weight lossYes57 (52.78%)
No51 (47.22%)
Economic situationGood25 (23.15%)
Rather good40 (37.04%)
Bad20 (18.52%)
Rather bad10 (9.26%)
Difficult to say13 (12.04%)
Reduced food intakeYes60 (55.56%)
No48 (44.44%)
Patients soliciting nutritional informationYes71 (68%)
No33 (31%)
Types of nutrition supportOral nutrition80 (74.07%)
Enteral nutrition28 (25.92%)
Seeking consultation with a dietitianYes67 (62.04)
No41 (37.96%)
Visited a dietitianYes67 (62.03%)
No41 (37.96%)
Mean ± SD95% CIMedian * (IQR)
Age58.20 ± 14.3855.44–60.9760 (21.75)
% Weight loss9.52 ± 8.847.82–11.239.95 (14.73)
BMI24.31 ± 4.8223.38–25.2423.49 (7.28)
* Non-distribution based on the Shapiro–Wilk test (p < 0.05); BMI—Body Mass Index.
Table 2. Cancer sites in the study group.
Table 2. Cancer sites in the study group.
Cancer Site According to ICD 10NameNumber (%)
C04Malignant neoplasm of floor of mouth10 (9.26)
C14Malignant neoplasm of other and ill-defined sites in the lip, oral cavity, and pharynx16 (14.81)
C15Malignant neoplasm of esophagus10 (9.26)
C16Malignant neoplasm of stomach5 (4.63)
C17Malignant neoplasm of small intestine1 (0.93)
C18Malignant neoplasm of colon4 (3.70)
C22Malignant neoplasm of liver and intrahepatic bile ducts4 (3.70)
C24Malignant neoplasm of other and unspecified parts of biliary tract1 (0.93)
C25Malignant neoplasm of pancreas3 (2.78)
C32Malignant neoplasm of larynx20 (18.52)
C34Malignant neoplasm of bronchus and lung4 (3.70)
C50Malignant neoplasm of breast10 (9.26)
C54Malignant neoplasm of corpus uteri1 (0.93)
C56Malignant neoplasm of ovary11 (10.18)
C61Malignant neoplasm of prostate8 (7.41)
Table 3. Mean and median scores of the five functional scales, global quality of life scale, three symptom scales, and six individual symptom scales of the EORTC QLQ-C30.
Table 3. Mean and median scores of the five functional scales, global quality of life scale, three symptom scales, and six individual symptom scales of the EORTC QLQ-C30.
MeasuresSubdomainMean Score ± SDMedian (IQR) *95%CICronbach’s Alpha
Coefficient
Functional scalesPhysical65.56 ± 26.0973.33 (40.0)60.58–70.530.82
Role56.33 ± 34.3966.67 (50.0)49.77–62.890.86
Cognitive69.6 ± 27.7075.0 (50.0)64.31–74.880.51
Emotional59.34 ± 28.0966.67 (37.5)53.98–64.690.66
Social49.54 ± 30.9550.0 (33.33)43.63–55.440.71
Global health status44.68 ± 21.3641.67 (29.17)40.60–48.75-
Symptom scalesFatigue48.46 ± 29.2044.44 (33.33)42.89–54.030.70
Pain42.90 ± 34.3533.33 (58.33)36.35–49.450.88
Vomiting/nausea10.34 ± 17.160.0 (16.67)7.07–13.610.58
Single-item measuresDyspnea19.14 ± 29.250.0 (33.33)13.56–24.72-
Insomnia46.30 ± 33.7533.33 (33.33)39.86–52.73-
Appetite loss27.16 ± 31.6233.33 (33.33)21.13–33.19-
Constipation24.38 ± 31.110 (33.33)18.45–30.32-
Diarrhea17.90 ± 30.380 (33.33)12.11–23.70-
Financial difficulties35.49 ± 35.3833.33 (66.67)28.74–42.24-
* Non-distribution based on the Shapiro–Wilk test (p < 0.05).
Table 4. Mean and median scores of the five functional scales, global quality of life scale, three symptom scales, and six individual symptom scales of the EORTC QLQ-C30, stratified by the gender of the analyzed group.
Table 4. Mean and median scores of the five functional scales, global quality of life scale, three symptom scales, and six individual symptom scales of the EORTC QLQ-C30, stratified by the gender of the analyzed group.
MeasuresSubdomainFemale (n = 58)Male (n = 50)p-Value
Mean Score ± SDMedian (IQR)95%CIMean Score ± SDMedian (IQR)95%CI
Functional scalesPhysical62.53 ± 24.4363.33 (46.67) *40–86.6769.07 ± 27.7380 (40) *53.33–93.330.0836
Role52.59 ± 33.1666.67 (33.33) *33.33–66.6760.67 ± 35.666.67 (66.67) *33.33–1000.1974
Cognitive61.78 ± 28.166.67 (50) *33.33–83.3378.67 ± 24.5283.33 (33.33) *66.67–1000.0011
Emotional50.29 ± 28.5750 (33.33)33.33–66.6769.83 ± 23.7475 (33.33) *58.33–91.670.0002
Social43.68 ± 30.0833.33 (50) *16.67–66.6756.33 ± 30.8466.67 (50) *33.33–83.330.0267
Global health status38.51 ± 18.5933.33 (25) *25–5051.83 ± 22.2950 (33.33)33.33–66.670.0029
Symptom scalesFatigue56.90 ± 28.1655.56 (44.44) *33.33–77.7838.67 ± 27.5133.33 (33.33) *22.22–55.560.0008
Pain45.69 ± 34.4233.33 (66.67) *16.67–83.3339.67 ± 34.3233.33 (66.67) *0–66.670.3686
Vomiting/
nausea
10.63 ± 17.850 (16.67) *0–16.6710 ± 16.50 (16.67) *0–16.670.8703
Single-item measuresDyspnea22.41 ± 32.070 (33.33) *0–33.3315.33 ± 25.390 (33.33) *0–33.330.2695
Insomnia51.15 ± 33.7550 (33.33) *33.33–66.6740.67 ± 33.1933.33 (66.67) *0–66.670.1109
Appetite loss28.16 ± 31.7233.33 (33.33) *0–33.3326 ± 31.7916.67 (33.33) *0–33.330.6607
Constipation22.41 ± 30.20 (33.33) *0–33.3326.67 ± 32.316.67 (33.33) *0–33.330.4562
Diarrhea20.69 ± 32.340 (33.33) *0–33.3314.67 ± 27.90 (33.33) *0–33.330.3182
Financial difficulties40.8 ± 38.5133.33 (66.67) *0–66.6729.33 ± 30.633.33 (33.33) *0–33.330.1626
* Non-distribution based on the Shapiro–Wilk test (p < 0.05).
Table 5. Results of the five functional scales, global quality of life scale, three symptom scales, and six individual symptom scales of the EORTC QLQ-C30, stratified by the reported recent decrease in food intake.
Table 5. Results of the five functional scales, global quality of life scale, three symptom scales, and six individual symptom scales of the EORTC QLQ-C30, stratified by the reported recent decrease in food intake.
MeasuresSubdomainGroup 1 (n = 60)Group 2 (n = 48)p-Value
Mean Score ± SDMedian (IQR)95%CIMean Score ± SDMedian (IQR)95%CI
Functional scalesPhysical63 ± 25.4166.67 (43.33) *43.33–86.6768.75 ± 26.8580 (33.33) *53.33–86.670.1488
Role55 ± 34.6266.67 (50) *33.33–83.3357.99 ± 34.3866.67 (50) *33.33–83.330.6340
Cognitive60.56 ± 27.6166.67 (50) *33.33–83.3380.9 ± 23.5783.33 (33.33) *66.67–1000.0001
Emotional54.17 ± 28.4858.33 (41.67) *33.33–7565.8 ± 26.4866.67 (25) *58.33–83.330.0236
Social46.11 ± 32.0941.67 (50) *16.67–66.6753.82 ± 29.2266.67 (41.67) *33.33–750.1848
Global health status40.42 ± 20.2341.67 (25)25–5050 ± 21.7450 (33.33)33.33–66.670.0198
Symptom scalesFatigue51.3 ± 27.3844.44 (33.33) *33.33–66.6744.91 ± 31.2638.89 (44.44) *22.22–66.670.2140
Pain49.17 ± 32.6833.33 (50) *33.33–83.3335.07 ± 35.133.33 (50) *0–500.0324
Vomiting/nausea12.22 ± 18.380 (16.67) *0–16.677.99 ± 15.370 (16.67) *0–16.670.3553
Single-item measuresDyspnea23.89 ± 32.530 (33.33) *0–33.3313.19 ± 23.560 (33.33) *0–33.330.1378
Insomnia53.33 ± 34.8366.67 (33.33) *33.33–66.6737.5 ± 30.4633.33 (66.67) *0–66.670.0204
Appetite loss37.78 ± 33.8833.33 (66.67) *0–66.6713.89 ± 22.630 (33.33) *0–33.330.0002
Constipation25.56 ± 32.110 (33.33) *0–33.3322.92 ± 30.10 (33.33) *0–33.330.7338
Diarrhea18.33 ± 31.550 (33.33) *0–33.3317.36 ± 29.160 (33.33) *0–33.330.9630
Financial difficulties37.22 ± 36.3633.33 (66.67) *0–66.6733.33 ± 34.3833.33 (33.33) *0–33.330.6362
* Non-distribution based on Shapiro–Wilk test (p < 0.05); Group 1—individuals reported recent decrease in food intake; Group 2—individuals who did not report recent decrease in food intake.
Table 6. Results of the five functional scales, global quality of life scale, three symptom scales, and six individual symptom scales of the EORTC QLQ-C30, stratified by reported consultation with a dietitian.
Table 6. Results of the five functional scales, global quality of life scale, three symptom scales, and six individual symptom scales of the EORTC QLQ-C30, stratified by reported consultation with a dietitian.
MeasuresSubdomainGroup 1 (n = 67)Group 2 (n = 41)p-Value
Mean Score ± SDMedian (IQR)95%CIMean Score ± SDMedian (IQR)95%CI
Functional scalesPhysical64.58 ± 25.5673.33 (40) *46.67–86.6767.15 ± 27.1873.33 (53.33) *40–93.330.4783
Role49 ± 36.2250 (66.67) *16.67–83.3368.29 ± 27.5966.67 (50) *50–1000.0087
Cognitive64.43 ± 29.8666.67 (66.67) *33.33–10078.05 ± 21.5583.33 (33.33) *66.67–1000.0299
Emotional55.97 ± 28.4958.33 (33.33) *41.67–7564.84 ± 26.8466.67 (41.67) *41.67–83.330.1263
Social45.27 ± 31.3633.33 (50) *16.67–66.6756.5 ± 29.3266.67 (50) *33.33–83.330.0790
Global health status41.79 ± 19.8141.67 (16.67) *33.33–5049.39 ± 23.1550 (33.33) *33.33–66.670.0632
Symptom scalesFatigue53.23 ± 28.5944.44 (44.44) *33.33–77.7840.65 ± 28.8333.33 (33.33) *22.22–55.560.0292
Pain48.01 ± 35.7150 (66.67) *16.67–83.3334.55 ± 30.5933.33 (16.67) *16.67–33.330.0707
Vomiting/nausea13.18 ± 19.580 (16.67) *0–16.675.69 ± 10.940 (16.67) *0–16.670.1194
Single-item measuresDyspnea22.89 ± 31.360 (33.33) *0–33.3313.01 ± 24.580 (33.33) *0–33.330.1676
Insomnia48.76 ± 31.4233.33 (33.33) *33.33–66.6742.28 ± 37.2933.33 (66.67) *0–66.670.3051
Appetite loss33.33 ± 33.8333.33 (66.67) *0–66.6717.07 ± 24.860 (33.33) *0–33.330.0181
Constipation25.37 ± 31.30 (33.33) *0–33.3322.76 ± 31.130 (33.33) *0–33.330.6440
Diarrhea21.39 ± 32.150 (33.33) *0–33.3312.2 ± 26.620 (0) *0–00.1454
Financial difficulties38.81 ± 35.133.33 (66.67) *0–66.6730.08 ± 35.5933.33 (33.33) *0–33.330.1705
* Non-distribution based on the Shapiro–Wilk test (p < 0.05); Group 1—individuals who reported consulting a dietitian; Group 2—individuals who did not report consulting a dietitian.
Table 7. Results of the five functional scales, global quality of life scale, three symptom scales, and six individual symptom scales of the EORTC QLQ-C30, stratified by having declared to solicit nutritional information.
Table 7. Results of the five functional scales, global quality of life scale, three symptom scales, and six individual symptom scales of the EORTC QLQ-C30, stratified by having declared to solicit nutritional information.
MeasuresSubdomainGroup 1 (n = 71)Group 2 (n = 37)p-Value
Mean Score ± SDMedian (IQR)95%CIMean Score ± SDMedian (IQR)95%CI
Functional scalesPhysical61.31 ± 27.9460 (46.67) *40–86.6773.69 ± 20.0680 (40) *53.33–93.330.0354
Role50.47 ± 34.1550 (50) *16.67–66.6767.57 ± 32.3866.67 (50) *50–1000.0127
Cognitive63.85 ± 28.7366.67 (50) *33.33–83.3380.63 ± 22.0583.33 (33.33) *66.67–1000.0027
Emotional54.11 ± 28.3158.33 (41.67) *33.33–7569.37 ± 25.0875 (50) *41.67–91.670.0029
Social43.19 ± 30.4233.33 (50) *16.67–66.6761.71 ± 28.5666.67 (50) *33.33–83.330.0025
Global health status40.96 ± 19.333.33 (25) *25–5025.23 ± 27.6733.33 (33.33)0–33.330.0161
Symptom scalesFatigue55.09 ± 29.655.56 (44.44) *33.33–77.7830.63 ± 32.0433.33 (50) *0–500.0006
Pain49.30 ± 33.9733.33 (66.67) *16.67–83.338.56 ± 17.40 (16.67) *0–16.670.0031
Vomiting/nausea11.27 ± 17.080 (16.67) *0–16.6718.92 ± 30.970 (33.33) *0–33.330.4523
Single-item measuresDyspnea19.25 ± 28.540 (33.33) *0–33.3336.94 ± 31.2133.33 (66.67) *0–66.670.7441
Insomnia51.17 ± 34.1966.67 (33.33) *33.33–66.6731.53 ± 36.8133.33 (66.67) *0–66.670.0277
Appetite loss24.88 ± 28.5733.33 (33.33) *0–33.3320.72 ± 28.710 (33.33) *0–33.330.6421
Constipation26.29 ± 32.330 (33.33) *0–33.3311.71 ± 22.520 (33.33) *0–33.330.5225
Diarrhea21.13 ± 33.450 (33.33) *0–33.3325.23 ± 27.6733.33 (33.33) *0–33.330.3717
Financial difficulties40.85 ± 37.8833.33 (66.67) *0–66.6730.63 ± 32.0433.33 (50) *0–500.0502
* Non-distribution based on the Shapiro–Wilk test (p < 0.05); Group 1—individuals who soliciting nutritional information; Group 2—individuals who did not solicit nutritional information.
Table 8. Stepwise multiple regression analysis for QoL (global health status) in a model including five functional scales (physical, role, cognitive, emotional, and social) and three symptom scales (fatigue, pain, and nausea/vomiting) as variables.
Table 8. Stepwise multiple regression analysis for QoL (global health status) in a model including five functional scales (physical, role, cognitive, emotional, and social) and three symptom scales (fatigue, pain, and nausea/vomiting) as variables.
Unstandardized
Coefficients
Standardized Coefficients βp
βSE
Constant 11.70070.0181
Functional scales—physical functioning0.49090.07440.4018<0.0001
Functional scales—social functioning0.27880.07650.19250.0004
Appetite loss−0.15800.0735−0.106730.0340
SE—standard error.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Gliwska, E.; Głąbska, D.; Zaczek, Z.; Sobocki, J.; Guzek, D. Multifactorial Analysis of Influences on Quality of Life in Cancer Patients. Nutrients 2024, 16, 3207. https://doi.org/10.3390/nu16183207

AMA Style

Gliwska E, Głąbska D, Zaczek Z, Sobocki J, Guzek D. Multifactorial Analysis of Influences on Quality of Life in Cancer Patients. Nutrients. 2024; 16(18):3207. https://doi.org/10.3390/nu16183207

Chicago/Turabian Style

Gliwska, Elwira, Dominika Głąbska, Zuzanna Zaczek, Jacek Sobocki, and Dominika Guzek. 2024. "Multifactorial Analysis of Influences on Quality of Life in Cancer Patients" Nutrients 16, no. 18: 3207. https://doi.org/10.3390/nu16183207

APA Style

Gliwska, E., Głąbska, D., Zaczek, Z., Sobocki, J., & Guzek, D. (2024). Multifactorial Analysis of Influences on Quality of Life in Cancer Patients. Nutrients, 16(18), 3207. https://doi.org/10.3390/nu16183207

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop